The main purpose of the study, called NAVIGATE (CD388.SQ.2.05), is to see if CD388 is well tolerated and safe in a large number of individuals. The study will also look for the dose of CD388 that may be most effective in preventing influenza infection that causes symptoms.
A screening visit is your first visit to our facility and takes roughly 2-4 hours. After filling out paperwork and reviewing a consent form, one of our nurses will go over the details to ensure your understanding.
This is the perfect time to ask any questions about the study and how your participation will affect you.
The nurse will then go over your medical history and take vitals.
The next step is completing a physical with our doctor. If our doctor deems you healthy enough for the study, you will then see our phlebotomist for a blood draw.
The night before:
The morning of:
First, you can ask our nurses any questions that come to your mind at any point of the process. But some good examples are:
Informed consent is the process of our volunteers being given all the information about the study. For your protection, all clinical trial facilities MUST give you all the details (including risks and benefits) pertaining to the study before you give consent to volunteer. All volunteers must sign the informed consent before they can participate in a trial. As the study progresses, there could be additional informed consent forms that require your signature.
JCCT takes this process very seriously. You will be given 1 on 1 time with one of our nurses to go over the consent form and ask as many questions as you need before you sign.
Based on your response, it looks like you don’t qualify. However, we have other opportunities that you may be qualified for. Fill out the form below to join our mailing list and be informed when new opportunities are available.
JCCT 197